Search
for
Sort by
Research 121–150 of 1000+
- Cytostatics and immunosuppressive drugs
- Management of CAH during pregnancy
- Polycystic ovary syndrome
- Optimized polycystic ovarian disease prognosis and classification using AI based computational approaches on multi-modality data
- Management of Hirsutism Associated With Obese PCOD - A Case Report
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Polycystic ovary syndrome
- Obesity and the skin: Skin physiology and skin manifestations of obesity
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- The PDGF/PDGFR pathway as a drug target
- Hormonal Therapy for Acne
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Infertility in Polycystic Ovary Syndrome: Focus on Low-Dose Gonadotropin Treatment
- Cutaneous Side Effects of Oral Contraceptives
- Acquired hypertrichosis lanuginosa: Case report and review of the literature
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Period problems: disorders of menstruation in adolescents
- Insulin resistance and the long-term consequences of polycystic ovary syndrome
- New approaches to the treatment of osteoporosis
- Dapsone Therapy for Pustular Psoriasis: Case Series and Review of the Literature
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- The Suitability of Polycystic Ovary Syndrome-Specific Questionnaires for Measuring the Impact of PCOS on Quality of Life in Clinical Trials
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?